Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
2023 · Experimental Hematology and Oncology · 14 citations
https://doi.org/10.1186/s40164-023-00409-y